PubMed

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study.

Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA.

Ann Intern Med. 1993 Nov 15;119(10):963-8.PMID: 8105737 [PubMed - indexed for MEDLINE]Related articlesFree article

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.

Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.

Ann Intern Med. 1996 Dec 15;125(12):961-8.PMID: 8967706 [PubMed - indexed for MEDLINE]Related articlesFree article

Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: a randomized, double-blind, placebo-controlled trial.

Lems WF, Lodder MC, Lips P, Bijlsma JW, Geusens P, Schrameijer N, van de Ven CM, Dijkmans BA.

Osteoporos Int. 2006;17(5):716-23. Epub 2006 Feb 3.PMID: 16463007 [PubMed - indexed for MEDLINE]Related articles

Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.

Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.

J Rheumatol. 1997 Aug;24(8):1489-94.PMID: 9263140 [PubMed - indexed for MEDLINE]Related articles

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A.

Ann Intern Med. 2002 Dec 3;137(11):875-83.PMID: 12458987 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.

van Everdingen AA, Jacobs JW, Siewertsz Van Reesema DR, Bijlsma JW.

Ann Intern Med. 2002 Jan 1;136(1):1-12.PMID: 11777359 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.

Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.

Ann Rheum Dis. 2009 Mar;68(3):373-6. Epub 2008 Apr 13.PMID: 18408246 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?

van Everdingen AA, Siewertsz van Reesema DR, Jacobs JW, Bijlsma JW.

Clin Exp Rheumatol. 2003 Mar-Apr;21(2):155-60.PMID: 12747268 [PubMed - indexed for MEDLINE]Related articles

Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound.

Frediani B, Falsetti P, Baldi F, Acciai C, Filippou G, Marcolongo R.

Bone. 2003 Oct;33(4):575-81.PMID: 14555261 [PubMed - indexed for MEDLINE]Related articles

Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.

Furst DE, Saag K, Fleischmann MR, Sherrer Y, Block JA, Schnitzer T, Rutstein J, Baldassare A, Kaine J, Calabrese L, Dietz F, Sack M, Senter RG, Wiesenhutter C, Schiff M, Stein CM, Satoi Y, Matsumoto A, Caldwell J, Harris RE, Moreland LW, Hurd E, Yocum D, Stamler DA.

Arthritis Rheum. 2002 Aug;46(8):2020-8.PMID: 12209503 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids.

Habib GS, Haj S.

Clin Rheumatol. 2005 Apr;24(2):129-33. Epub 2004 Sep 14.PMID: 15372317 [PubMed - indexed for MEDLINE]Related articles

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.

Pitt P, Li F, Todd P, Webber D, Pack S, Moniz C.

Thorax. 1998 May;53(5):351-6.PMID: 9708225 [PubMed - indexed for MEDLINE]Related articlesFree article

Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content.

Laan RF, Buijs WC, van Erning LJ, Lemmens JA, Corstens FH, Ruijs SH, van de Putte LB, van Riel PL.

Calcif Tissue Int. 1993 Jan;52(1):5-9.PMID: 8453505 [PubMed - indexed for MEDLINE]Related articles

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.

Lange U, Teichmann J, Müller-Ladner U, Strunk J.

Rheumatology (Oxford). 2005 Dec;44(12):1546-8. Epub 2005 Nov 1.PMID: 16263785 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.

Cortet B, Hachulla E, Barton I, Bonvoisin B, Roux C.

Rev Rhum Engl Ed. 1999 Apr;66(4):214-9.PMID: 10339777 [PubMed - indexed for MEDLINE]Related articles

Fluoride therapy in prevention of rheumatoid arthritis induced bone loss.

Adachi JD, Bell MJ, Bensen WG, Bianchi F, Cividino A, Sebaldt RJ, Gordon M, Ioannidis G, Goldsmith C.

J Rheumatol. 1997 Dec;24(12):2308-13.PMID: 9415633 [PubMed - indexed for MEDLINE]Related articles

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mallée C, de Beus WM, de Sonnaville PB, Ewals JA, Breedveld FC, Dijkmans BA.

Ann Intern Med. 2007 Mar 20;146(6):406-15.PMID: 17371885 [PubMed - indexed for MEDLINE]Related articlesFree article

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.

Cohen SB, Dore RK, Lane NE, Ory PA, Peterfy CG, Sharp JT, van der Heijde D, Zhou L, Tsuji W, Newmark R; Denosumab Rheumatoid Arthritis Study Group.

Arthritis Rheum. 2008 May;58(5):1299-309.PMID: 18438830 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.

Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR.

Ann Intern Med. 1996 Sep 1;125(5):360-8.PMID: 8702086 [PubMed - indexed for MEDLINE]Related articlesFree article

Evaluation of bone mineral density in patients with rheumatoid arthritis. Influence of disease activity and glucocorticoid therapy.

Cortet B, Flipo RM, Blanckaert F, Duquesnoy B, Marchandise X, Delcambre B.

Rev Rhum Engl Ed. 1997 Jul-Sep;64(7-9):451-8.PMID: 9338926 [PubMed - indexed for MEDLINE]Related articles